New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searching for innovative therapeutic approaches for the neurodegenerative diseases

2016/23/N/NZ7/00475

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Michał Karol Załuski

Number of co-investigators in the project: 3

Call

PRELUDIUM 12 – announced on 2016-09-15

Amount awarded
96 200 PLN
Project start date
2017-10-02
Project end date
2020-04-01
Project duration
30 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. sonda światłowodowa do syntetyzatora mikrofalowego CEM Discovery. Cost: 5 000 PLN

Information in the final report

Publication in academic press/journals (3)

  1. 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A2A receptors. Design, synthesis and biological evaluation.

    Authors:
    Michał Załuski, Jakub Schabikowski, Piotr Jaśko, Adrian Bryła, Agnieszka Olejarz-Maciej, Maria Kaleta, Monika Głuch-Lutwin, Andreas Brockmann, Sonja Hinz, Małgorzata Zygmunt, Kamil Kuder, Gniewomir Latacz, Christin Vielmuth, Christa E. Müller, Katarzyna Kieć- Kononowicz
    Academic press:
    Bioorganic Chemistry (year: 2020, volume: 101, pages: brak), Publisher: Elsevier Ltd
    Status:
    Published
    DOI:
    10.1016/j.bioorg.2020.104033. – link to the publication
  2. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies

    Authors:
    Michał Załuski, Jakub Schabikowski, Miriam Schlenk, Agnieszka Olejarz-Maciej, Bartłomiej Kubas, Tadeusz Karcz, Kamil Kuder, Gniewomir Latacz, Małgorzata Zygmunt, David Synak, Sonja Hinz, Christa E. Müller, Katarzyna Kieć-Kononowicz
    Academic press:
    Bioorganic & Medicinal Chemistry (year: 2019, volume: 27, pages: 1195-1210), Publisher: Elsevier Ltd
    Status:
    Published
    DOI:
    10.1016/j.bmc.2019.02.004. – link to the publication
  3. Novel, Dual Target‐Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B.

    Authors:
    Kuder, K.J., Załuski, M., Schabikowski, J., Latacz, G., Olejarz‐Maciej, A., Jaśko, P., Doroz‐Płonka, A., Brockmann, A., Müller, C.E. and Kieć‐Kononowicz, K.
    Status:
    Accepted for publication

« New search

Graphic design and implementation: Jakub Piotrowski